DOTA-NI-FAPI-04
DOTA-NI-FAPI-04 is a potent FAP inhibitor (IC50 7.44 nM) designed for dual targeting of tumor stroma and hypoxia. By chelating radionuclides like 68Ga and 177Lu, it enables targeted PET imaging and radionuclide therapy research, facilitating studies of the tumor microenvironment in preclinical models.
Product Specifications
Smiles
C1CN (CCN1CCCOC2=CC3=C (C=CN=C3C=C2) C (=O) NCC (=O) N4CC (C[C@H]4C#N) (F) F) C (=O) [C@H] (CCC (=O) NCCCN5C=CN=C5[N+] (=O) [O-]) NC (=O) CN6CCN (CCN (CCN (CC6) CC (=O) O) CC (=O) O) CC (=O) O
Molecular Formula
C51H69F2N15O14
Molecular Weight
1154.18
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
D-1730.0001 1.0g
Fmoc-Nle-SASRIN resin (200-400 mesh, 0.5-0.8 mmol/g)
Sign In for Pricing
View Details 
DZ41346-Fluoro647 200 µL/Vial
Anti-TOLL pathway signalling NF-kappaB Relish-like transcription factor/REL1 Antibody Fluoro647 Conjugated
Sign In for Pricing
View Details orb2925078-01 20 µg
Recombinant Mouse Alpha-1,3/1,6-mannosyltransferase ALG2 (Alg2)
Sign In for Pricing
View Details orb2925078-02 100 µg
Recombinant Mouse Alpha-1,3/1,6-mannosyltransferase ALG2 (Alg2)
Sign In for Pricing
View Details